Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intensification of HIV therapy with maraviroc in patients with insufficient immune restoration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maraviroc (maraviroc)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infection, HIV Infections | Phase 2 | Status: COMPLETED